Rabbit Anti-CD82 Recombinant Antibody (VS13-YC178) (CAT#: VS13-YC178)
The Rabbit Anti-CD82 Recombinant Antibody is specific for human CD82. CD82, a metastasis suppressor, antagonizes tumor pathways by interacting with transcription inhibitors like p53, influencing cancer progression and cellular pathways through expression control. The anti-CD82 antibody can be used for Immunohistochemistry (1/100-1/200).
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

(Immunofluorescent staining of human cell line RH-30 shows localization to vesicles.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/61418/1143_C8_4_selected.jpg

(Immunohistochemical staining of human appendix shows strong positivity in lymphoid tissue.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28900/64792_A_2_2_selected.jpg

(Immunohistochemical staining of human tonsil shows distinct positivity of reticular fibers.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/2508/ihc_selected.jpg

(Immunofluorescent staining of human cell line U-2 OS shows localization to nucleoli.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/61418/1130_C8_1_blue_red_green.jpg

(Immunofluorescent staining of human cell line U-251 MG shows localization to vesicles.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/61418/1242_A11_1_blue_red_green.jpg

(Neuropil
Staining: Medium
Intensity: Moderate
Quantity:>75%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28900/64792_B_9_5.jpg

(Pancreatic endocrine cells
Staining: Medium
Intensity: Moderate
Quantity:>75%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28900/64792_A_1_3.jpg

(Collecting ducts
Staining: Medium
Intensity: Moderate
Quantity: 75%-25%
Distal tubules
Staining: Medium
Intensity: Moderate
Quantity: 75%-25%)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28900/64792_A_9_5.jpg

(Germinal center cells
Staining: Medium
Intensity: Strong
Quantity: <25%
Location: Cytoplasmic/membranous
Non-germinal center cells
Staining: Medium
Intensity: Moderate
Quantity: 75%-25%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/28900/64792_A_7_8.jpg

(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000085117-CD82

(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000085117-CD82
Specifications
- Immunogen
- Recombinant human CD82.
- Host Species
- Rabbit
- Type
- Rabbit IgG
- Specificity
- Human CD82
- Species Reactivity
- Human
- Applications
- IHC-P
- Conjugate
- NONE
- Related Disease
- Prostate cancer
Product Property
- Clonality
- Monoclonal
- Purification
- Affinity Chromatography purified
- Format
- Liquid
- Concentration
- Please refer to the vial label for the specific concentration.
- Buffer
- PBS (pH 7.1) containing 50% Glycerol and 0.5% BSA.
- Preservative
- 0.02% Sodium azide
- Storage
- Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
- Shipping
- Shipping with ice pack.
Applications
- Application Notes
- Immunohistochemistry (IHC): 1/100-1/200
Target
- Alternative Names
- CD82 Molecule; CD82 Antigen; Kangai 1 (Suppression Of Tumorigenicity 6, Prostate; CD82 Antigen (R2 Leukocyte Antigen, Antigen Detected By Monoclonal And Antibody IA4)); Metastasis Suppressor Kangai-1; Inducible Membrane Protein R2; Tetraspanin-27; C33 Antigen; Tspan-27; TSPAN27; KAI1; SAR2;
- Gene ID
- 3732
- UniProt ID
- P27701
- Long Name
- CD82 Molecule
- Cellular Localization
- Cell membrane
- Protein Refseq
- XP_011518369.1; XP_047282856.1; XP_047282857.1; XP_047282859.1; XP_047282860.1
- Function
- Associates with CD4 or CD8 and delivers costimulatory signals for the TCR/CD3 pathway.
Recommended Products
Secondary Antibody
Isotype Control
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "CD82"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1186z | Mouse Anti-CD82 Recombinant Antibody (clone 28B4) | WB, FC, ICC, IHC, IP, FuncS | Mouse IgG2a |
MOB-1605MZ | Recombinant Mouse Anti-Human CD82 Antibody (clone C-M3), PE-Conjugated | FC | Mouse antibody |
VS3-FY322 | Recombinant Mouse Anti-CD82 Antibody (clone 5D5D5) | ELISA, WB, IHC, FC | Mouse IgG1 |
VS3-FY323 | Recombinant Mouse Anti-CD82 Antibody (clone 7G8G4) | ELISA, IHC, FC | Mouse IgG2a |
VS3-XY3301 | Rabbit Anti-CD82 Recombinant Antibody (clone R06-7K5) | WB, IHC-P, FC | Rabbit IgG |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS13-YC178. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: WB, Neut, FuncS
Application: ELISA
Application: Neut, FC
Application: ELISA, FC, IF, IHC, WB
Application: ELISA, Neut
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.